Purpose of Review
We review recent epidemiological and clinical studies investigating the consumption of tree nuts and peanuts and cardiovascular disease (CVD) mortality as well as CVD risk factors.
A greater consumption of tree nuts and peanuts is associated with a reduced risk of CVD mortality, as well as lower CVD events. Furthermore, risk factors associated with the development of CVD such as dyslipidemia, impaired vascular function, and hypertension are improved with regular tree nut and peanut consumption through a range of mechanism associated with their nutrient-rich profiles. There is weak inconsistent evidence for an effect of nut consumption on inflammation. There is emerging evidence that consuming tree nuts reduces the incidence of non-alcoholic fatty liver disease (NAFLD) and promotes diversity of gut microbiota, which in turn may improve CVD outcomes.
Evidence for CVD prevention is strong for some varieties of tree nuts, particularly walnuts, and length of supplementation and dose are important factors for consideration with recommendations.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
O’Neil CE, Fulgoni VL, 3rd, Nicklas TA: Tree nut consumption is associated with better adiposity measures and cardiovascular and metabolic syndrome health risk factors in U.S. adults: NHANES 2005–2010. Nutr J 2015, 14:64.
Freisling H, Noh H, Slimani N, Chajès V, May AM, Peeters PH, et al. Nut intake and 5-year changes in body weight and obesity risk in adults: results from the EPIC-PANACEA study. Eur J Nutr. 2017;
Jackson CL, Hu FB: Long-term associations of nut consumption with body weight and obesity. Am J Clin Nutr 2014, 100 Suppl 1:408s–411s.
Tan SY, Dhillon J, Mattes RD: A review of the effects of nuts on appetite, food intake, metabolism, and body weight. Am J Clin Nutr 2014, 100 Suppl 1:412s–422s.
•• Kim Y, Keogh JB, Clifton PM. Benefits of nut consumption on insulin resistance and cardiovascular risk factors: multiple potential mechanisms of actions. Nutrients. 2017;9(11) Recent and comprehensive review of the mechanisms by which nuts reduce risk for CVD and type 2 diabetes.
Hernandez-Alonso P, Camacho-Barcia L, Bullo M, Salas-Salvado J: Nuts and dried fruits: an update of their beneficial effects on type 2 diabetes. Nutrients 2017, 9(7).
Ros E. Nuts and CVD. Br J Nutr. 2015;113(Suppl 2):S111–20.
USDA National Nutrient Database for Standard Reference; Release 28, Version Current: September 2015; /nea/bhnrc/ndl.
Terzo S, Baldassano S, Caldara GF, Ferrantelli V, Lo Dico G, Mulè F, et al. Health benefits of pistachios consumption. Nat Prod Res. 2017:1–12.
Rusu ME, Gheldiu AM, Mocan A, Vlase L, Popa DS. Anti-aging potential of tree nuts with a focus on the phytochemical composition, molecular mechanisms and thermal stability of major bioactive compounds. Food Funct. 2018;9(5):2554–75.
Stuetz W, Schlormann W, Glei M. B-vitamins, carotenoids and alpha-/gamma-tocopherol in raw and roasted nuts. Food Chem. 2017;221:222–7.
Brown RC, Tey SL, Gray AR, Chisholm A, Smith C, Fleming E, et al. Nut consumption is associated with better nutrient intakes: results from the 2008/09 New Zealand Adult Nutrition Survey. Br J Nutr. 2016;115(1):105–12.
Griel AE, Eissenstat B, Juturu V, Hsieh G, Kris-Etherton PM. Improved diet quality with peanut consumption. J Am Coll Nutr. 2004;23(6):660–8.
O’Neil CE, Nicklas TA, Fulgoni VL. Tree nut consumption is associated with better nutrient adequacy and diet quality in adults: National Health and Nutrition Examination Survey 2005-2010. Nutrients. 2015;7(1):595–607.
Rehm CD, Drewnowski A. Replacing American snacks with tree nuts increases consumption of key nutrients among US children and adults: results of an NHANES modeling study. Nutr J. 2017;16(1):17.
Barbour JA, Stojanovski E, Moran LJ, Howe PRC, Coates AM. The addition of peanuts to habitual diets is associated with lower consumption of savory non-core snacks by men and sweet non-core snacks by women. Nutr Res. 2017;41:65–72.
Burns AM, Zitt MA, Rowe CC, Langkamp-Henken B, Mai V, Nieves C Jr, et al. Diet quality improves for parents and children when almonds are incorporated into their daily diet: a randomized, crossover study. Nutr Res. 2016;36(1):80–9.
Pearson KR, Tey SL, Gray AR, Chisholm A, Brown RC. Energy compensation and nutrient displacement following regular consumption of hazelnuts and other energy-dense snack foods in non-obese individuals. Eur J Nutr. 2017;56(3):1255–67.
Bitok E, Jaceldo-Siegl K, Rajaram S, Serra-Mir M, Roth I, Feitas-Simoes T, et al. Favourable nutrient intake and displacement with long-term walnut supplementation among elderly: results of a randomised trial. Br J Nutr. 2017;118(3):201–9.
Neale EP, Tapsell LC, Martin A, Batterham MJ, Wibisono C, Probst YC. Impact of providing walnut samples in a lifestyle intervention for weight loss: a secondary analysis of the HealthTrack trial. Food Nutr Res. 2017;61(1):1344522.
Kranz S, Hill AM, Fleming JA, Hartman TJ, West SG, Kris-Etherton PM. Nutrient displacement associated with walnut supplementation in men. J Hum Nutr Diet. 2014;27(Suppl 2):247–54.
Sterling SR, Bertrand B, Judd S, Baskin ML. Nut intake among overweight and obese African-American women in the rural south. Am J Health Behav. 2016;40(5):585–93.
Choi Y, Abdelmegeed MA, Song BJ. Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice. J Nutr Biochem. 2016;38:70–80.
Berryman CE, Grieger JA, West SG, Chen CYO, Blumberg JB, Rothblat GH, et al. Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia. J Nutr. 2013;143(6):788–94.
Berryman CE, Fleming JA, Kris-Etherton PM. Inclusion of almonds in a cholesterol-lowering diet improves plasma HDL subspecies and cholesterol efflux to serum in normal-weight individuals with elevated LDL cholesterol. J Nutr. 2017;147(8):1517–23.
Holligan SD, West SG, Gebauer SK, Kay CD, Kris-Etherton PM. A moderate-fat diet containing pistachios improves emerging markers of cardiometabolic syndrome in healthy adults with elevated LDL levels. Br J Nutr. 2014;112(5):744–52.
Toledo E, Wang DD, Ruiz-Canela M, Clish CB, Razquin C, Zheng Y, et al. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. Am J Clin Nutr. 2017;106(4):973–83.
Fumeron F, Bard JM, Lecerf JM. Interindividual variability in the cholesterol-lowering effect of supplementation with plant sterols or stanols. Nutr Rev. 2017;75(2):134–45.
Calcabrini C, De Bellis R, Mancini U, Cucchiarini L, Stocchi V, Potenza L. Protective effect of Juglans regia L. walnut extract against oxidative DNA damage. Plant Foods Hum Nutr. 2017;72(2):192–7.
Gormaz JG, Valls N, Sotomayor C, Turner T, Rodrigo R. Potential role of polyphenols in the prevention of cardiovascular diseases: molecular bases. Curr Med Chem. 2016;23(2):115–28.
Huguenin GV, Oliveira GM, Moreira AS, et al. Improvement of antioxidant status after Brazil nut intake in hypertensive and dyslipidemic subjects. Nutr J. 2015;14:54.
Rocchetti G, Chiodelli G, Giuberti G, Lucini L. Bioaccessibility of phenolic compounds following in vitro large intestine fermentation of nuts for human consumption. Food Chem. 2018;245:633–40.
Eslamparast T, Sharafkhah M, Poustchi H, Hashemian M, Dawsey SM, Freedman ND, et al. Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study. Int J Epidemiol. 2017;46(1):75–85.
Gopinath B, Flood VM, Burlutksy G, Mitchell P. Consumption of nuts and risk of total and cause-specific mortality over 15 years. Nutr Metab Cardiovasc Dis. 2015;25(12):1125–31.
Guasch-Ferre M, Liu X, Malik VS, et al. Nut consumption and risk of cardiovascular disease. J Am Coll Cardiol. 2017;70(20):2519–32.
• Hshieh TT, Petrone AB, Gaziano JM, Djousse L. Nut consumption and risk of mortality in the Physicians’ Health Study. Am J Clin Nutr. 2015;101(2):407–12. This paper suggests that nut intake of 1–3 servings/month is not likely to provide protection against CVD mortality when compared to at least 2–4 servings/week.
Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100(1):278–88.
•• Aune D, Keum N, Giovannucci E, et al. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14(1):207. This meta-analysis conducted separate analyses for tree and ground nuts. Peanuts was reported to show slightly lower relative risks for CVD events than tree nuts.
Bechthold A, Boeing H, Schwedhelm C, Hoffmann G, Knüppel S, Iqbal K, et al. Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2017:1–20.
Chen GC, Zhang R, Martinez-Gonzalez MA, et al. Nut consumption in relation to all-cause and cause-specific mortality: a meta-analysis 18 prospective studies. Food Funct. 2017;8(11):3893–905.
Deng C, Lu Q, Gong B, Li L, Chang L, Fu L, et al. Stroke and food groups: an overview of systematic reviews and meta-analyses. Public Health Nutr. 2018;21(4):766–76.
• Grosso G, Yang J, Marventano S, Micek A, Galvano F, Kales SN. Nut consumption on all-cause, cardiovascular, and cancer mortality risk: a systematic review and meta-analysis of epidemiologic studies. Am J Clin Nutr. 2015;101(4):783–93. This study examined the dose-response relationship between nut consumption and all-cause and CVD mortality.
Mayhew AJ, de Souza RJ, Meyre D, Anand SS, Mente A. A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br J Nutr. 2016;115(2):212–25.
Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knüppel S, Iqbal K, et al. Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2017;105(6):1462–73.
van den Brandt PA, Schouten LJ. Relationship of tree nut, peanut and peanut butter intake with total and cause-specific mortality: a cohort study and meta-analysis. Int J Epidemiol. 2015;44(3):1038–49.
Zhang Z, Xu G, Wei Y, Zhu W, Liu X. Nut consumption and risk of stroke. Eur J Epidemiol. 2015;30(3):189–96.
Shao C, Tang H, Zhao W, He J. Nut intake and stroke risk: a dose-response meta-analysis of prospective cohort studies. Sci Rep. 2016;6:30394.
Schwingshackl L, Hoffmann G, Missbach B, Stelmach-Mardas M, Boeing H. An umbrella review of nuts intake and risk of cardiovascular disease. Curr Pharm Des. 2017;23(7):1016–27.
Del Gobbo LC, Falk MC, Feldman R, Lewis K, Mozaffarian D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am J Clin Nutr. 2015;102(6):1347–56.
Mah E, Schulz JA, Kaden VN, Lawless AL, Rotor J, Mantilla LB, et al. Cashew consumption reduces total and LDL cholesterol: a randomized, crossover, controlled-feeding trial. Am J Clin Nutr. 2017;105(5):1070–8.
Jamshed H, Sultan FA, Iqbal R, Gilani AH. Dietary almonds increase serum HDL cholesterol in coronary artery disease patients in a randomized controlled trial. J Nutr. 2015;145(10):2287–92.
Mohan V, Gayathri R, Jaacks LM, Lakshmipriya N, Anjana RM, Spiegelman D, et al. Cashew nut consumption increases HDL cholesterol and reduces systolic blood pressure in Asian Indians with type 2 diabetes: a 12-week randomized controlled trial. J Nutr. 2018;148(1):63–9.
Le T, Flatt SW, Natarajan L, et al. Effects of diet composition and insulin resistance status on plasma lipid levels in a weight loss intervention in women. J Am Heart Assoc. 2016:5(1).
Rock CL, Flatt SW, Barkai HS, Pakiz B, Heath DD. Walnut consumption in a weight reduction intervention: effects on body weight, biological measures, blood pressure and satiety. Nutr J. 2017;16(1):76.
Abazarfard Z, Salehi M, Keshavarzi S. The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: a randomized controlled clinical trial. J Res Med Sci. 2014;19(5):457–64.
Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56(2):320–8.
Rolland C, Broom I. The effects of very-low-calorie diets on HDL: a review. Cholesterol. 2011;2011:306278.
Jenkins DJA, Kendall CWC, Lamarche B, Banach MS, Srichaikul K, Vidgen E, et al. Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial. Diabetologia. 2018;61:1734–47.
Fischer S, Schatz U, Julius U. Practical recommendations for the management of hyperlipidemia. Atheroscler Suppl. 2015;18:194–8.
•• Ruisinger JF, Gibson CA, Backes JM, et al. Statins and almonds to lower lipoproteins (the STALL study). J Clin Lipidol. 2015;9(1):58–64. This paper demonstrates that almonds can provide additional cholesterol-lowering benefits to statin therapy.
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–12.
Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26(6):631–40.
Huang Y, Zheng S, Wang T, Yang X, Luo Q, Li H. Effect of oral nut supplementation on endothelium-dependent vasodilation - a meta-analysis. Vasa. 2018:1–5.
• Neale EP, Tapsell LC, Guan V, Batterham MJ. The effect of nut consumption on markers of inflammation and endothelial function: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2017;7(11):e016863. An important meta-analysis evaluating the effects of nuts on endothelial function and biochemical markers of vascular health (inflammation).
Xiao Y, Huang W, Peng C, et al. Effect of nut consumption on vascular endothelial function: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2017;
Fogacci F, Cicero AFG, Derosa G, Rizzo M, Veronesi M, Borghi C. Effect of pistachio on brachial artery diameter and flow-mediated dilatation: a systematic review and meta-analysis of randomized, controlled-feeding clinical studies. Crit Rev Food Sci Nutr. 2017:1–8.
Liu X, Hill AM, West SG, Gabauer RM, McCrea CE, Fleming JA, et al. Acute peanut consumption alters postprandial lipids and vascular responses in healthy overweight or obese men. J Nutr. 2017;147(5):835–40.
Axtell AL, Gomari FA, Cooke JP: Assessing endothelial vasodilator function with the Endo-PAT 2000. J Vis Exp 2010(44).
Sauder KA, McCrea CE, Ulbrecht JS, Kris-Etherton PM, West SG. Pistachio nut consumption modifies systemic hemodynamics, increases heart rate variability, and reduces ambulatory blood pressure in well-controlled type 2 diabetes: a randomized trial. Hypertension. 2014;3:e000873.
Sauder KA, McCrea CE, Ulbrecht JS, Kris-Etherton PM, West SG. Effects of pistachios on the lipid/lipoprotein profile, glycemic control, inflammation, and endothelial function in type 2 diabetes: a randomized trial. Metabolism. 2015;64(11):1521–9.
Huguenin GV, Moreira AS, Siant’Pierre TD, et al. Effects of dietary supplementation with Brazil nuts on microvascular endothelial function in hypertensive and dyslipidemic patients: a randomized crossover placebo-controlled trial. Microcirculation. 2015;22(8):687–99.
Kasliwal RR, Bansal M, Mehrotra R, Yeptho KP, Trehan N. Effect of pistachio nut consumption on endothelial function and arterial stiffness. Nutrition. 2015;31(5):678–85.
Chen CY, Holbrook M, Duess MA, et al. Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial. Nutr J. 2015;14:61.
Barbour JA, Howe PR, Buckley JD, Bryan J, Coates AM. Cerebrovascular and cognitive benefits of high-oleic peanut consumption in healthy overweight middle-aged adults. Nutr Neurosci. 2016:1–8.
Choudhury K, Clark J, Griffiths HR. An almond-enriched diet increases plasma alpha-tocopherol and improves vascular function but does not affect oxidative stress markers or lipid levels. Free Radic Res. 2014;48(5):599–606.
Mohammadifard N, Salehi-Abargouei A, Salas-Salvado J, Guasch-Ferre M, Humphries K, Sarrafzadegan N. The effect of tree nut, peanut, and soy nut consumption on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials. Am J Clin Nutr. 2015;101(5):966–82.
McKay DL, Eliasziw M, Chen CYO, Blumberg JB: A pecan-rich diet improves cardiometabolic risk factors in overweight and obese adults: a randomized controlled trial. Nutrients 2018, 10(3).
Tey SL, Robinson T, Gray AR, Chisholm AW, Brown RC. Do dry roasting, lightly salting nuts affect their cardioprotective properties and acceptability? Eur J Nutr. 2017;56(3):1025–36.
Dhillon J, Tan SY, Mattes RD. Almond consumption during energy restriction lowers truncal fat and blood pressure in compliant overweight or obese adults. J Nutr. 2016;146(12):2513–9.
Ndanuko RN, Tapsell LC, Charlton KE, Neale EP, Batterham MJ. Effect of individualised dietary advice for weight loss supplemented with walnuts on blood pressure: the HealthTrack study. Eur J Clin Nutr. 2018;72:894–903.
Yu Z, Malik VS, Keum N, Hu FB, Giovannucci EL, Stampfer MJ, et al. Associations between nut consumption and inflammatory biomarkers. Am J Clin Nutr. 2016;104(3):722–8.
Medina-Remon A, Casas R, Tressserra-Rimbau A, et al. Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial. Br J Clin Pharmacol. 2017;83(1):114–28.
Barbour JA, Howe PR, Buckley JD, Bryan J, Coates AM. Effect of 12 weeks high oleic peanut consumption on cardio-metabolic risk factors and body composition. Nutrients. 2015;7(9):7381–98.
Mazidi M, Rezaie P, Ferns GA, Gao HK. Impact of different types of tree nut, peanut, and soy nut consumption on serum C-reactive protein (CRP): a systematic review and meta-analysis of randomized controlled clinical trials. Medicine (Baltimore). 2016;95(44):e5165.
Chen CM, Liu JF, Li SC, Huang CL, Hsirh AT, Weng SF, et al. Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial. Nutr Metab (Lond). 2017;14:51.
Gulati S, Misra A, Pandey RM. Effect of almond supplementation on glycemia and cardiovascular risk factors in Asian Indians in North India with type 2 diabetes mellitus: a 24-week study. Metab Syndr Relat Disord. 2017;15(2):98–105.
Liu Y, Hwang HJ, Ryu H, Lee YS, Kim HS, Park H. The effects of daily intake timing of almond on the body composition and blood lipid profile of healthy adults. Nutr Res Pract. 2017;11(6):479–86.
Jung H, Chen CO, Blumberg JB, Kwak HK. The effect of almonds on vitamin E status and cardiovascular risk factors in Korean adults: a randomized clinical trial. Eur J Nutr. 2017;
George ES, Forsyth A, Itsiopoulos C, Nicoll AJ, Ryan M, Sood S, et al. Practical dietary recommendations for the prevention and management of nonalcoholic fatty liver disease in adults. Adv Nutr. 2018;9(1):30–40.
Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms. Liver Int. 2017;37(7):936–49.
Han JM, Jo AN, Lee SM, Bae HS, Jun DW, Cho YK, et al. Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2014;29(6):1265–72.
•• Cueto-Galan R, Baron FJ, Valdivielso P, et al. Changes in fatty liver index after consuming a Mediterranean diet: 6-year follow-up of the PREDIMED-Malaga trial. Med Clin (Barc). 2017;148(10):435–43. Incorporating nuts into a Mediterranean diet was associated with a lower fatty liver index.
Yamashita T, Kasahara K, Emoto T, Matsumoto T, Mizoguchi T, Kitano N, et al. Intestinal immunity and gut microbiota as therapeutic targets for preventing atherosclerotic cardiovascular diseases. Circ J. 2015;79(9):1882–90.
Ahmadmehrabi S, Tang WHW. Gut microbiome and its role in cardiovascular diseases. Curr Opin Cardiol. 2017;32(6):761–6.
Lamuel-Raventos RM, Onge MS. Prebiotic nut compounds and human microbiota. Crit Rev Food Sci Nutr. 2017;57(14):3154–63.
Bamberger C, Rossmeier A, Lechner K, et al. A walnut-enriched diet affects gut microbiome in healthy Caucasian subjects: a randomized, controlled trial. Nutrients. 2018:10(2).
Holscher HD, Guetterman HM, Swanson KS, An R, Matthan NR, Lichtenstein AH, et al. Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: a randomized controlled trial. J Nutr. 2018;148(6):861–7.
•• Holscher HD, Taylor AM, Swanson KS, Novotny JA, Baer DJ. Almond consumption and processing affects the composition of the gastrointestinal microbiota of healthy adult men and women: a randomized controlled trial. Nutrients. 2018;10(2) A RCT demonstrating that incorporating almonds promotes diversity of gut microbiota, which in turn may improve CVD outcomes.
Hernandez-Alonso P, Canueto D, Giardina S, et al. Effect of pistachio consumption on the modulation of urinary gut microbiota-related metabolites in prediabetic subjects. J Nutr Biochem. 2017;45:48–53.
Micha R, Shulkin ML, Penalvo JL, et al. Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS One. 2017;12(4):e0175149.
Anagnostis P, Paschou SA, Goulis DG, Athyros VG, Karagiannis A. Dietary management of dyslipidaemias. Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit? Maturitas. 2018;108:45–52.
Conflict of Interest
Dr. Coates reports grants from the Peanut Company of Australia, the Almond Board of California, the Almond Board of Australia, and the International Nut and Dried Fruit Council, outside the submitted work. Dr. Tan reports grants from Almond Board of California, outside the submitted work. Dr. Hill reports grants from Almond Board of California, the Almond Board of Australia, and the International Nut and Dried Fruit Council, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Nutrition
About this article
Cite this article
Coates, A., Hill, A. & Tan, S. Nuts and Cardiovascular Disease Prevention. Curr Atheroscler Rep 20, 48 (2018). https://doi.org/10.1007/s11883-018-0749-3
- Nuts; cardiovascular diseases
- Vascular stiffness